No significant difference in the concentrations of BUN (10, IQR 8–12 vs 3, IQR 18–31; P ═ 0.067), urine albumin (5.2, IQR 4.5–9.3 vs 12.8, IQR 9.4–14.2; P ═ 0.074), and eGFR (79, IQR 72–80 vs 24, IQR 19–31; P ═ 0.051) was seen between group treated with the combination of rosuvastatin RD and curcumin and the CKD control group (Table 1 and Figure 4). Here, ALB is linked to chronic kidney disease.